1
|
Lyczak JB, Cannon CL and Pier GB:
Establishment of Pseudomonas aeruginosa infection: Lessons from a
versatile opportunist. Microbes Infect. 2:1051–1060. 2000.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Rowe SM, Miller S and Sorscher EJ: Cystic
Fibrosis. N Engl J Med. 352:1992–2001. 2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Nicas TI and Hancock RE: Pseudomonas
aeruginosa outer membrane permeability: Isolation of a porin
protein F-deficient mutant. J Bacteriol. 153:281–285.
1983.PubMed/NCBI
|
4
|
Breidenstein EB, de la Fuente-Núñez C and
Hancock RE: Pseudomonas aeruginosa: All roads lead to resistance.
Trends Microbiol. 19:419–426. 2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Pasupuleti M, Schmidtchen A and Malmsten
M: Antimicrobial peptides: Key component of the innate immune
system. Crit Rev Biotechnol. 32:143–171. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Li Y, Xiang Q, Zhang Q, Huang Y and Su Z:
Overview on the recent study of antimicrobial peptides: Origins,
functions, relative mechanisms and application. Peptides.
37:207–215. 2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Zasloff M: Antimicrobial peptides of
multicellular organisms. Nature. 415:389–395. 2002. View Article : Google Scholar : PubMed/NCBI
|
8
|
Shang D, Sun Y, Wang C, Wei S, Ma L and
Sun L: Membrane interaction and antibacterial properties of
chensinin-1, an antimicrobial peptide with atypical structural
features from the skin of Rana chensinensis. Appl Microbiol
Biotechnol. 96:1551–1560. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Shang D, Yu F, Li J, Zheng J and Li Y:
Molecular cloning of cDNAs encoding antimicrobial peptide
precursors from the skin of the Chinese brown frog, Rana
chensinensis. Zoolog Sci. 26:220–226. 2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Chan DI, Prenner EJ and Vogel HJ:
Tryptophan- and arginine-rich antimicrobial peptides: Structures
and mechanisms of action. Biochim Biophys Acta. 1758:1184–1202.
2006. View Article : Google Scholar : PubMed/NCBI
|
11
|
Yau WM, Wimley WC, Gawrisch K and White
SH: The preference of tryptophan for membrane interfaces.
Biochemistry. 37:14713–14718. 1998. View Article : Google Scholar : PubMed/NCBI
|
12
|
Dong W, Mao X, Guan Y, Kang Y and Shang D:
Antimicrobial and anti-inflammatory activities of three chensinin-1
peptides containing mutation of glycine and histidine residues. Sci
Rep. 7:402282017. View Article : Google Scholar : PubMed/NCBI
|
13
|
Pal T, Abraham B, Sonnevend A, Jumaa P and
Conlon JM: Brevinin-1BYa: A naturally occurring peptide from frog
skin with broad-spectrum antibacterial and antifungal properties.
Int J Antimicrob Agents. 27:525–529. 2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Saiman L, Mehar F, Niu WW, Neu HC, Shaw
KJ, Miller G and Prince A: Antibiotic susceptibility of multiply
resistant Pseudomonas aeruginosa isolated from patients with cystic
fibrosis, including candidates for transplantation. Clin Infect
Dis. 23:532–537. 1996. View Article : Google Scholar : PubMed/NCBI
|
15
|
Reller LB, Schoenknecht FD, Kenny MA and
Sherris JC: Antibiotic susceptibility testing of Pseudomonas
aeruginosa: Selection of a control strain and criteria for
magnesium and calcium content in media. J Infect Dis. 130:454–463.
1974. View Article : Google Scholar : PubMed/NCBI
|
16
|
Working party on antibiotic sensitivity
testing of the britishsociety for antimicrobial chemotherapy.
report of the working party on antibiotic sensitivity testing of
the British Society for Antimicrobial Chemotherapy. A guide to
sensitivity testing. J Antimicrob Chemother. 27:41–43. 1991.
|
17
|
Sun Y, Dong W, Sun L, Ma L and Shang D:
Insights into the membrane interaction mechanism and antibacterial
properties of chensinin-1b. Biomaterials. 37:299–311. 2015.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Gilchrist JE, Campbell JE, Donnelly CB,
Peeler JT and Delaney JM: Spiral plate method for bacterial
determination. Appl Microbiol. 25:244–252. 1973.PubMed/NCBI
|
19
|
Saravanan R, Mohanram H, Joshi M, Domadia
PN, Torres J, Ruedl C and Bhattacharjya S: Structure, activity and
interactions of the cysteine deleted analog of tachyplesin-1 with
lipopolysaccharide micelle: Mechanistic insights into
outer-membrane permeabilization and endotoxin neutralization.
Biochim Biophys Acta. 1818:1613–1624. 2012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Beckloff N, Laube D, Castro T, Furgang D,
Park S, Perlin D, Clements D, Tang H, Scott RW, Tew GN and Diamond
G: Activity of an antimicrobial peptide mimetic against planktonic
and biofilm cultures of oral pathogens. Antimicrob Agents
Chemother. 51:4125–4132. 2007. View Article : Google Scholar : PubMed/NCBI
|
21
|
Shang D, Zhang Q, Dong W, Liang H and Bi
X: The effects of LPS on the activity of Trp-containing
antimicrobial peptides against Gram-negative bacteria and endotoxin
neutralization. Acta Biomater. 33:153–165. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ma L, Jackson KD, Landry RM, Parsek MR and
Wozniak DJ: Analysis of Pseudomonas aeruginosa conditional psl
variants reveals roles for the psl polysaccharide in adhesion and
maintaining biofilm structure postattachment. J Bacteriol.
188:8213–8221. 2006. View Article : Google Scholar : PubMed/NCBI
|
23
|
Friedman L and Kolter R: Two genetic loci
produce distinct carbohydrate-rich structural components of the
Pseudomonas aeruginosa biofilm matrix. J Bacteriol. 186:4457–4465.
2004. View Article : Google Scholar : PubMed/NCBI
|
24
|
Matsukawa M and Greenberg EP: Putative
exopolysaccharide synthesis genes influence Pseudomonas aeruginosa
biofilm development. J Bacteriol. 186:4449–4456. 2004. View Article : Google Scholar : PubMed/NCBI
|
25
|
Wei GX, Campaqna AN and Bobek LA: Effect
of MUC7 peptides on the growth of bacteria and on Streptococcus
mutans biofilm. J Antimicrob Chemother. 57:1100–1009. 2006.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
27
|
Sharma KK, Sangraulah H and Mediratta PK:
Some new concepts in antibacterial drug therapy. Indian J Pharm.
34:390–396. 2002.
|
28
|
Ryder C, Byrd M and Wozniak DJ: Role of
polysaccharides in Pseudomonas aeruginosa biofilm development. Curr
Opin Microbiol. 10:644–648. 2007. View Article : Google Scholar : PubMed/NCBI
|
29
|
Ghafoor A, Hay ID and Rehm BH: Role of
exopolysaccharides in Pseudomonas aeruginosa biofilm formation and
architecture. Appl Environ Microbiol. 77:5238–5246. 2011.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Xie J, Gou Y, Zhao Q, Wang K, Yang X, Yan
J, Zhang W, Zhang B, Ma C and Wang R: Antimicrobial activities and
membrane-active mechanism of CPF-C1 against multidrug-resistant
bacteria, a novel antimicrobial peptide derived from skin
secretions of the tetraploid frog Xenopus clivii. J Pept Sci.
20:876–884. 2014. View
Article : Google Scholar : PubMed/NCBI
|
31
|
Torrent M, Navarro S, Moussaoui M, Nogués
MV and Boix E: Eosinophil cationic protein high-affinity binding to
bacteria wall lipopolysaccharides and peptidoglycans. Biochemistry.
47:3544–3555. 2008. View Article : Google Scholar : PubMed/NCBI
|
32
|
Li XZ, Zhang L and Poole AK: Interplay
between the MexA-MexB-OprM multidrug efflux system and the outer
membrane barrier in the multiple antibiotic resistance of
Pseudomonas aeruginosa. J Antimicrob Chemother. 45:433–436. 2000.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Høiby N, Bjarnsholt T, Givskov M, Molin S
and Ciofu O: Antibiotic resistance of bacterial biofilms. Int J
Antimicrob Agents. 35:322–332. 2010. View Article : Google Scholar : PubMed/NCBI
|